Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.

Aslam AA, Sinha IP, Southern KW

DOI: 10.1002/14651858.cd012040.pub3
Published: 2023 Mar 3
Container: The Cochrane database of systematic reviews
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/14651858.cd012040.pub3,
  title = {Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.},
  author = {Aslam AA and Sinha IP and Southern KW},
  year = {2023},
  journal = {The Cochrane database of systematic reviews},
  doi = {10.1002/14651858.cd012040.pub3},
  url = {https://doi.org/10.1002/14651858.cd012040.pub3}
}

RIS

TY  - JOUR
TI  - Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
AU  - Aslam AA
AU  - Sinha IP
AU  - Southern KW
PY  - 2023
JO  - The Cochrane database of systematic reviews
DO  - 10.1002/14651858.cd012040.pub3
UR  - https://doi.org/10.1002/14651858.cd012040.pub3
ER  -

APA

AA, A., IP, S., & KW, S. (2023). Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd012040.pub3

Source records

pubmed · retrieved 2026-09-25T13:04:41.550Z